I've been waiting for some giant to save this struggling company, and here it is: Valeant Pharmaceuticals International received a joint takeover offer from Japan’s Takeda Pharmaceutical and TPG Capital Management this spring that the Canadian drugmaker rejected, according to a source familiar with the matter. The offer was made a few weeks before Joseph Papa took over as Valeant’s new chief executive in April, the source told Reuters. The board wants to give Papa time to focus on running the company before thinking about a sale offer, the source said. Takeda and private equity firm TPG were ready to offer a substantial premium to Valeant, whose stock had fallen about 65% this year up to the close of trade on April 22 as the drugmaker was not just seeking a new head but was also hit by an accounting scandal, the source added. Valeant could jump crazily on today's session! $BHC, Bausch Health Companies Inc. / 1440